Patent · US Active

Fused heterocyclic compounds

US7615552B2 · kind B2 · utility

87Cited by

12References

46Claims

0Family size

Assignee

Synta Pharmaceuticals Corp. · US

Inventors

Mitsunori Ono · Lexington, US
Lijun Sun · Harvard, US
Yumiko Wada · Waltham, US
Teresa Przewloka · Tewksbury, US
Hao Li · Brookline, US
Zachary Demko · Los Altos, US
Dinesh U. Chimmanamada · Arlington, US

Key dates

Filing date	Nov 10, 2004
Grant date	Nov 10, 2009
Priority date	—
Expiry date	Dec 2, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides fused heterocyclic compounds, pharmaceutical compositions of the compounds, and methods of using the compounds for the treatment of, inter alia, IL-12 related disease and disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.